AtaGenix Laboratories

Home - Support Center - Case Studies - AbPro™ Antibody

AtaGenix’s Customized ATG8 Antibody Solutions for Studying Amino Acid Metabolism Reprogramming in BmNPV-Infected Silkworms

Release time: 2025-08-04   View volume: 381

Project Snapshot — A sericulture virology team studying how BmNPV reprograms host amino acid metabolism needed a highly specific ATG8 polyclonal antibody to detect autophagy markers in silkworm cells. AtaGenix delivered a custom rabbit anti-ATG8 antibody with ELISA titer >1:64,000 and >90% purity, validated for IF and WB — enabling a publication in PLOS Pathogens (2025).

Research Background

Bombyx mori nucleopolyhedrovirus (BmNPV) is a major pathogen in sericulture, causing substantial economic losses. The virus supports its replication by reprogramming host amino acid metabolism — specifically, BmNPV upregulates the amino acid transporter Slc7a6 to enhance arginine uptake and induces mitochondrial autophagy (mitophagy) to maintain intracellular amino acid levels, thereby fueling viral proliferation through an “exogenous uptake–endogenous supply” dual mechanism. The research was published in PLOS Pathogens (2025, DOI: 10.1371/journal.ppat.1013331).

Client Needs

The research team aimed to elucidate how BmNPV reprograms amino acid metabolism in silkworm cells. They required: (1) a highly specific ATG8 antibody to detect autophagy markers induced by BmNPV infection via immunofluorescence (IF) and Western Blot (WB); (2) compatibility with laser confocal microscopy for quantitative mitophagy analysis using Fiji software; (3) sufficient sensitivity to distinguish autophagy levels between BmNPV-infected and uninfected BmN cells; and (4) reliable performance alongside Slc7a6 knockout validation and viral titer (TCID50) assays.

Technical Challenges

Developing an ATG8 antibody for insect virology research presented specific hurdles:

  • ATG8 is a small, highly conserved autophagy marker — the antibody had to specifically detect the silkworm (Bombyx mori) form without cross-reacting with non-autophagy-related ubiquitin-like proteins.
  • The antibody needed to work across both IF (native/fixed cells for confocal imaging) and WB (denatured protein for quantification) platforms with minimal background.
  • BmNPV-induced mitophagy involves dynamic ATG8 lipidation (ATG8-PE conjugation) — the antibody had to detect both free ATG8 and lipidated ATG8-II forms on WB for accurate autophagy flux measurement.
  • Commercial antibodies validated for mammalian LC3/ATG8 do not reliably cross-react with insect ATG8, necessitating a custom solution.

Customized Solutions

AtaGenix designed a targeted antibody development workflow for this insect biology application:

  • Immunogen Optimization: AtaGenix analyzed the Bombyx mori ATG8 protein sequence, identified immunogenic regions with maximum divergence from non-target ubiquitin-like proteins, and designed an optimized immunogen peptide. KLH conjugation ensured robust immune response in New Zealand rabbits.
  • Polyclonal Antibody Production: Rabbits were immunized with the optimized ATG8 immunogen. Serum was collected after titer confirmation, and antibodies were purified by Protein A/G affinity chromatography to >90% purity with ELISA titer exceeding 1:64,000.
  • Dual-Platform Validation: The anti-ATG8 antibody was validated for IF (laser confocal microscopy with Fiji-based quantification of mitophagy puncta) and WB (detection of both ATG8-I and lipidated ATG8-II bands). Optimized staining conditions and WB dilution ratios were provided in the QC report.
  • Comprehensive QC Package: AtaGenix delivered detailed quality control documentation including SDS-PAGE purity analysis, ELISA titer data, batch consistency verification, and recommended experimental conditions for each application platform.

Research Outcomes and Impact

The custom ATG8 antibody enabled the research team to validate that BmNPV infection induces mitochondrial autophagy in silkworm cells and that the virus maintains amino acid homeostasis through this autophagy-driven endogenous supply mechanism. Combined with Slc7a6 knockout experiments (demonstrating reduced arginine uptake and viral titer), qPCR targeting the viral gene vp39, and TCID50 viral titer assays, the team fully elucidated the “exogenous uptake (Slc7a6) – endogenous supply (mitophagy)” dual mechanism by which BmNPV reprograms arginine metabolism to support replication. These findings provide new molecular targets for developing antiviral strategies in sericulture, with significant agricultural and economic implications.

Mitochondrial autophagy induced by BmNPV infection

Figure 1. BmNPV-induced mitochondrial autophagy in silkworm cells. AtaGenix custom anti-ATG8 antibody enabled confocal IF detection of autophagy puncta and WB quantification of ATG8 lipidation, confirming the virus-driven mitophagy mechanism that maintains amino acid homeostasis for viral replication.

ATG8
Custom Insect Target
>1:64,000
ELISA Titer
IF + WB
Dual-Platform Validated
PLOS Pathog.
Published 2025

About AtaGenix

AtaGenix provides one-stop customized support from antibody/protein design to functional validation, covering custom polyclonal and monoclonal antibodies, protein expression, phage display, and multi-platform validation — including non-standard species (insect, plant, aquatic) where commercial antibodies are unavailable. Learn more at www.atagenix.com.

This case study is based on a published research collaboration. Results may vary depending on target protein, host species, and experimental conditions. All proprietary client information is subject to NDA. Reference: PLOS Pathogens. 2025. DOI: 10.1371/journal.ppat.1013331

Need custom antibodies for insect, plant, or non-model organism targets where commercial reagents don’t exist? AtaGenix designs species-specific immunogens and delivers validated antibodies for any host.

Explore Polyclonal Antibody Service

Rapid Hybridoma  |  Peptide Synthesis  |  E. coli Expression  |  Insect / BEVS

Messages